EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice

Preety Panwar, Pierre Marie Andrault, Dipon Saha, Dieter Brömme iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.17312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, 2024. Verfasst von Preety Panwar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Phenanthrenes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Collaborative Health Research Projects, Canada Research Chairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation and painful joint destruction. Current treatments are helpful in RA remission, but strong immunosuppressive activity and patient resistance are clinical issues. This study explores a dual‐action inhibitor, possessing both anti‐inflammatory and anti‐resorptive properties, as a novel treatment for RA. Experimental Approach Therapeutic efficacy and mechanisms of ectosteric (tanshinone IIA sulfonate [T06]) and active site‐directed (odanacatib [ODN]) inhibitors of cathepsin K (CatK) were evaluated in RA mouse models. Pathology was assessed through biochemical analyses and histopathological examination. Flow cytometry analysis was performed to characterize immune cells. Anti‐inflammatory effects of T06 on nuclear factor kappa beta (NF‐κB) pathway were studied in macrophages. Key Results T06 effectively lowered the number of joint‐resident immune cells, accompanied by significantly reduced production of inflammatory cytokines and collagenolytic proteases. This also included the suppression of Th17 cells and IL‐17, resulting in the reduction of osteoclasts in arthritic joints and amplification of the overall anti‐resorptive effect of T06, which has been attributed to its selective inhibition of the collagenolytic activity of CatK by preventing its oligomerization. The anti‐inflammatory mechanism of T06 was based on blocking the phosphorylation of IκBα in the NF‐κB pathway, resulting in reduced activation and expression of inflammatory cytokines. In contrast, ODN had no effect on inflammation and disease progression and was limited to the inhibition of CatK. Conclusions The combined anti‐resorptive and anti‐inflammatory activities characterize T06 as a novel therapeutic agent for RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidPhenanthrenesAnimalsMiceMice, Inbred DBAMaleNF-kappa BArthritis, ExperimentalCathepsin KOsteoclastsAnti-Inflammatory Agents

Stichwörter der Autor:innen

NF‐κB pathwaycathepsin Kcytokinesimmune cellsinflammationosteoclasts

Substanzen

PhenanthrenesNF-kappa BCathepsin KAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
  • Centre for Blood Research, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Pharmaceutical Sciences, Elizabeth City State University, Elizabeth City, North Carolina, USA.
  • Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

ORCID-Profile: Dieter Brömme

Förderung

  • CIHR
  • Collaborative Health Research Projects
  • Canada Research Chairs
  • Canadian Institutes of Health Research

Zitieren

APA

Panwar, P., Andrault, P. M., Saha, D., & Brömme, D. (2024). Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice. British Journal of Pharmacology. https://doi.org/10.1111/bph.17312

Vancouver

Panwar P, Andrault PM, Saha D, Brömme D. Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice. British Journal of Pharmacology. 2024. doi:10.1111/bph.17312

BibTeX
@article{Panwar2024,
  author = {Panwar, Preety and Andrault, Pierre Marie and Saha, Dipon and Brömme, Dieter},
  title = {Immune regulatory and anti‐resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.17312}
}
Kostenlos starten →